Detail of the clinical trial

Title of the trial A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 versus Treatment Choice (TC) in Adults with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy
EudraCT number 2014-001233-89
Protocol number SGI-110-04
Sponsor Astex Pharmaceuticals, Inc., 4420 Rosewood Drive Ste 200, Pleasanton, CA 94588, United States of America
Indications Hemato-oncology
Diagnosis Myeloid leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2015
Date of approval by Institute (SÚKL) 23.4.2015
Date of approval by EC 13.5.2015
Date of initiation CT in ČR 4.8.2015
Date of ending CT in ČR 28.8.2018(30.5.2018)
Notice
Sites Všeobecná fakultní nemocnice ,I.interní klinika ? klinika hematologie,U nemocnice 2,128 08 Praha 2
Fakultní nemocnice Královské Vinohrady ,Interní hematologická klinika ,Šrobárova 1150/50,100 34 Praha 10
Fakultní nemocnice Brno,Interní hematologická a onkologická klinika,Jihlavská 20,625 00 Brno

‹‹ Back to list